Percent Change on the National Institutes of Health Stroke Scale

A Useful Acute Stroke Outcome Measure

Askiel Bruno, Chandan Saha, Linda S. Williams

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: A single optimal outcome measure in acute stroke has not been established. Changes in neurologic deficits might be useful outcome measures in acute stroke because they can measure within-subject changes on the entire spectrum of the scales starting at baseline. Methods: We tested the ability of percent National Institutes of Health Stroke Scale (NIHSS) score change (baseline-3 months) to predict the traditional functional outcomes in acute stroke (modified Rankin Scale [mRS], Barthel Index, Glasgow Outcome Scale, final NIHSS score). We analyzed data sets from two acute stroke clinical trials involving 44 clinical research centers throughout the United States and 1899 randomized patients. Results: The percent NIHSS score change predicted functional outcomes very well, all areas under the curve of 0.90 or greater with all P values less than .001 in receiver operating characteristic analysis. In the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator (rt-PA) Acute Stroke Trial, benefit from rt-PA was confirmed by a greater improvement on the NIHSS score than with placebo (67% v 50%, P < .002). In moderate stroke severity (baseline NIHSS score 7-15) an improvement of at least 55% was the best predictor of functional independence at 3 months (mRS ≤ 2). Conclusion: This novel approach to the NIHSS score as an outcome measure in acute stroke appears to be an additional useful analytic and communication tool.

Original languageEnglish (US)
Pages (from-to)56-59
Number of pages4
JournalJournal of Stroke and Cerebrovascular Diseases
Volume18
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

National Institutes of Health (U.S.)
Stroke
Outcome Assessment (Health Care)
Tissue Plasminogen Activator
National Institute of Neurological Disorders and Stroke
Glasgow Outcome Scale
Aptitude
Neurologic Manifestations
ROC Curve
Area Under Curve
Communication
Placebos
Clinical Trials

Keywords

  • Stroke outcomes
  • ischemic stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Rehabilitation
  • Cardiology and Cardiovascular Medicine

Cite this

Percent Change on the National Institutes of Health Stroke Scale : A Useful Acute Stroke Outcome Measure. / Bruno, Askiel; Saha, Chandan; Williams, Linda S.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 18, No. 1, 01.01.2009, p. 56-59.

Research output: Contribution to journalArticle

@article{97fc4be1c48044a58e84e8965465ed24,
title = "Percent Change on the National Institutes of Health Stroke Scale: A Useful Acute Stroke Outcome Measure",
abstract = "Background: A single optimal outcome measure in acute stroke has not been established. Changes in neurologic deficits might be useful outcome measures in acute stroke because they can measure within-subject changes on the entire spectrum of the scales starting at baseline. Methods: We tested the ability of percent National Institutes of Health Stroke Scale (NIHSS) score change (baseline-3 months) to predict the traditional functional outcomes in acute stroke (modified Rankin Scale [mRS], Barthel Index, Glasgow Outcome Scale, final NIHSS score). We analyzed data sets from two acute stroke clinical trials involving 44 clinical research centers throughout the United States and 1899 randomized patients. Results: The percent NIHSS score change predicted functional outcomes very well, all areas under the curve of 0.90 or greater with all P values less than .001 in receiver operating characteristic analysis. In the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator (rt-PA) Acute Stroke Trial, benefit from rt-PA was confirmed by a greater improvement on the NIHSS score than with placebo (67{\%} v 50{\%}, P < .002). In moderate stroke severity (baseline NIHSS score 7-15) an improvement of at least 55{\%} was the best predictor of functional independence at 3 months (mRS ≤ 2). Conclusion: This novel approach to the NIHSS score as an outcome measure in acute stroke appears to be an additional useful analytic and communication tool.",
keywords = "Stroke outcomes, ischemic stroke",
author = "Askiel Bruno and Chandan Saha and Williams, {Linda S.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2008.09.002",
language = "English (US)",
volume = "18",
pages = "56--59",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Percent Change on the National Institutes of Health Stroke Scale

T2 - A Useful Acute Stroke Outcome Measure

AU - Bruno, Askiel

AU - Saha, Chandan

AU - Williams, Linda S.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Background: A single optimal outcome measure in acute stroke has not been established. Changes in neurologic deficits might be useful outcome measures in acute stroke because they can measure within-subject changes on the entire spectrum of the scales starting at baseline. Methods: We tested the ability of percent National Institutes of Health Stroke Scale (NIHSS) score change (baseline-3 months) to predict the traditional functional outcomes in acute stroke (modified Rankin Scale [mRS], Barthel Index, Glasgow Outcome Scale, final NIHSS score). We analyzed data sets from two acute stroke clinical trials involving 44 clinical research centers throughout the United States and 1899 randomized patients. Results: The percent NIHSS score change predicted functional outcomes very well, all areas under the curve of 0.90 or greater with all P values less than .001 in receiver operating characteristic analysis. In the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator (rt-PA) Acute Stroke Trial, benefit from rt-PA was confirmed by a greater improvement on the NIHSS score than with placebo (67% v 50%, P < .002). In moderate stroke severity (baseline NIHSS score 7-15) an improvement of at least 55% was the best predictor of functional independence at 3 months (mRS ≤ 2). Conclusion: This novel approach to the NIHSS score as an outcome measure in acute stroke appears to be an additional useful analytic and communication tool.

AB - Background: A single optimal outcome measure in acute stroke has not been established. Changes in neurologic deficits might be useful outcome measures in acute stroke because they can measure within-subject changes on the entire spectrum of the scales starting at baseline. Methods: We tested the ability of percent National Institutes of Health Stroke Scale (NIHSS) score change (baseline-3 months) to predict the traditional functional outcomes in acute stroke (modified Rankin Scale [mRS], Barthel Index, Glasgow Outcome Scale, final NIHSS score). We analyzed data sets from two acute stroke clinical trials involving 44 clinical research centers throughout the United States and 1899 randomized patients. Results: The percent NIHSS score change predicted functional outcomes very well, all areas under the curve of 0.90 or greater with all P values less than .001 in receiver operating characteristic analysis. In the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator (rt-PA) Acute Stroke Trial, benefit from rt-PA was confirmed by a greater improvement on the NIHSS score than with placebo (67% v 50%, P < .002). In moderate stroke severity (baseline NIHSS score 7-15) an improvement of at least 55% was the best predictor of functional independence at 3 months (mRS ≤ 2). Conclusion: This novel approach to the NIHSS score as an outcome measure in acute stroke appears to be an additional useful analytic and communication tool.

KW - Stroke outcomes

KW - ischemic stroke

UR - http://www.scopus.com/inward/record.url?scp=57749117441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57749117441&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2008.09.002

DO - 10.1016/j.jstrokecerebrovasdis.2008.09.002

M3 - Article

VL - 18

SP - 56

EP - 59

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 1

ER -